A Promising Attenuated Rhabdovirus Vaccine Candidate Conferring Dual-Route Protection Against MSRV Disease in Largemouth Bass (Micropterus salmoides)
Vaccines · 16.06.2025 · 13 (6) · 645
DOI: 10.3390/vaccines13060645 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 16.06.2025. Verfasst von Xiaozhe Fu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Fishery Drug Development, Ministry of Agriculture and Rural Affairs, Guangdong Province Key Laboratory of Aquatic Animal Immune and…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Guangzhou City, S&T Projects of Shenzhen Science and Technology Innovation Committee, Science and Technology Program of Guangzhou.
Abstract (Originalsprache)
Background/Objectives: Largemouth bass rhabdovirus (Micropterus salmoides rhabdovirus, MSRV) disease causes high mortality in largemouth bass farming. Therefore, vaccine development is critical for largemouth bass prevention against MSRV.
Methods
An attenuated strain, denoted as MSRV-0509, was selected through intraperitoneal injection and immersion challenge assays, followed by plaque purification. The biological characteristics of MSRV-0509, including optimal inoculation dose, replication kinetics, thermostability, pH resistance, chloroform tolerance, and storage viability, were determined via viral titration. Spatiotemporal distribution patterns in largemouth bass post-intraperitoneal injection or immersion infection were quantified by qPCR. Immunoprotective efficacy was evaluated through intraperitoneal and immersion vaccination. Mechanistic insights were explored via relative qPCR and serum neutralization assays. Safety was assessed by single-dose overdose immunization and virulence reversion experiments.
Results
An attenuated strain MSRV-0509 was screened through a challenge assay, exhibiting complete avirulence in largemouth bass compared to the virulent strain SCRV-T6. MSRV-0509 demonstrated optimal replication at low MOI (0.0001) in CPB cells, with peak titers (108.3 TCID50/mL) at 96 h post-infection. The virus showed susceptibility to high temperatures, lipid solvents and acidic conditions, with prolonged stable storage viability at −80 °C. Tissue distribution revealed the spleen as the primary target after intraperitoneal injection, while immersion restricted infection to gills, with rapid clearance by 3–6 dpi. Vaccination trials identified 5 × 102 TCID50/fish via intraperitoneal injection and 106.0 TCID50/mL via immersion as effective immunizing doses, providing 100% relative survival post-challenge. Immune gene expression and serum neutralization showed Th1 and Th2 activation via intraperitoneal injection (elevated IL-12, IFN-γ, IL-10, IgM), whereas only the Th1 response was activated after vaccine immersion. No abnormality and mortality were observed in single overdose vaccination and virulence reversion experiments, confirming that MSRV-0509 was safe.
Conclusions
These results proved that MSRV-0509 could be a promising vaccine candidate to protect largemouth bass from MSRV disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Fishery Drug Development, Ministry of Agriculture and Rural Affairs, Guangdong Province Key Laboratory of Aquatic Animal Immune and Sustainable Aquaculture, Pearl River Fishery Research Institute, Chin…
- Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
Förderung
- Key Research and Development Program of Guangzhou City
- S&T Projects of Shenzhen Science and Technology Innovation Committee
- Science and Technology Program of Guangzhou
Zitieren
APA
Fu, X., Li, W., Kong, M., Liang, H., Lin, Q., Niu, Y., Luo, X., Ma, B., Zhou, J., & Li, N. (2025). A Promising Attenuated Rhabdovirus Vaccine Candidate Conferring Dual-Route Protection Against MSRV Disease in Largemouth Bass (Micropterus salmoides). Vaccines, 13(6), 645. https://doi.org/10.3390/vaccines13060645
Vancouver
Fu X, Li W, Kong M, Liang H, Lin Q, Niu Y, et al. A Promising Attenuated Rhabdovirus Vaccine Candidate Conferring Dual-Route Protection Against MSRV Disease in Largemouth Bass (Micropterus salmoides). Vaccines. 2025;13(6):645. doi:10.3390/vaccines13060645
BibTeX
@article{Fu2025,
author = {Fu, Xiaozhe and Li, Wenxian and Kong, Minghui and Liang, Hongru and Lin, Qiang and Niu, Yinjie and Luo, Xia and Ma, Baofu and Zhou, Jin and Li, Ningqiu},
title = {A Promising Attenuated Rhabdovirus Vaccine Candidate Conferring Dual-Route Protection Against MSRV Disease in Largemouth Bass (Micropterus salmoides)},
journal = {Vaccines},
year = {2025},
volume = {13},
number = {6},
pages = {645},
doi = {10.3390/vaccines13060645}
}
EUVIMED